One Liberty Properties Reports Second Quarter 2025 Results

(NYSE:OLP), – Enters Agreement to Acquire Industrial Property for $24.0 Million Bringing 2025 Acquisitions to Over $112 Million – – Completes Sale of Three Retail Assets for $6.5 Million Gain – GREAT NECK, N.Y., Aug. 05, 2025 (GLOBE NEWSWIRE) — One Liberty Properties, Inc. (NYSE: OLP), a real estate investment trust focused on industrial properties, […]

Airship AI Reports Second Quarter 2025 Financial Results

(NasdaqGM:AISP), Second Quarter 2025 Net Revenues of $2.1 Million, Gross Profit of $1.5 Million and Gross Margin of 71% Significant Customer Engagement Activities Throughout the Quarter Provide Strong Tailwinds Heading into Government Fiscal Year End New Pro-U.S. Border Security Administration Provides Additional Macro Tailwinds for 2025 & Beyond REDMOND, Wash., Aug. 05, 2025 (GLOBE NEWSWIRE)

ScottsMiracle-Gro Announces Changes to Board of Directors

(NYSE:SMG), MARYSVILLE, Ohio, Aug. 05, 2025 (GLOBE NEWSWIRE) — The Scotts Miracle-Gro Company (NYSE: SMG), the world's leading marketer of branded consumer lawn and garden products as well as a leader in indoor and hydroponic growing products, today announced changes to its Board of Directors. Former U.S. Army Lt. General John R. Vines announced his

Par Pacific Holdings Reports Second Quarter 2025 Results

(NYSE:PARR), HOUSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) — Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific” or the “Company”) today reported its financial results for the quarter ended June 30, 2025. Net Income of $59.5 million, or $1.17 per diluted share Adjusted Net Income of $78.3 million, or $1.54 per diluted share Adjusted EBITDA of

Interparfums, Inc. Reports 2025 Second Quarter and Half Year Results

(NASDAQ:IPAR), NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) — Interparfums, Inc. (NASDAQ GS: IPAR) today reported results for the second quarter and six months ended June 30, 2025. Financial Highlights:($ in millions, except per share amounts) Three Months EndedJune 30, Six Months EndedJune 30, 2025 2024 % Change 2025 2024 % Change Net Sales $334

Stride Achieves Another Record Year

(NYSE:LRN), RESTON, Va., Aug. 05, 2025 (GLOBE NEWSWIRE) — Stride, Inc. (NYSE: LRN), one of the nation's most successful technology-based education companies, today announced its results for the fourth quarter and full fiscal year ended June 30, 2025. Fiscal 2025 Highlights Compared to 2024 Revenue of $2,405.3 million, compared with $2,040.1 million Income from operations

Applied Optoelectronics to Present at the Rosenblatt 5th Annual Technology Summit: The Age of AI

(NasdaqGM:AAOI), SUGAR LAND, Texas, Aug. 05, 2025 (GLOBE NEWSWIRE) — Applied Optoelectronics, Inc. (NASDAQ: AAOI) (“AOI”), a leading provider of advanced optical and HFC networking products that power the internet, today announced the Company will virtually present via a fireside chat format at the following investor conference: Event: Rosenblatt 5th Annual Technology Summit: The Age

Powell Industries Announces Third Quarter Fiscal 2025 Results

(NASDAQ:POWL), HOUSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) — Powell Industries, Inc. (NASDAQ: POWL), a leading supplier of custom-engineered solutions for the management, control and distribution of electrical energy, today announced results for the third quarter of fiscal 2025 ended June 30, 2025. All comparisons are to the third quarter of fiscal 2024, unless otherwise noted.

Matthews International Reports Results for Fiscal 2025 Third Quarter

(NASDAQ:MATW), Fiscal 2025 Third Quarter Financial Highlights: GAAP Earnings per share of $0.49 vs. $0.06 a year ago Memorialization and Industrial Technologies report higher adjusted EBITDA Outstanding debt reduced by $120 million Company realizing benefits of cost reduction actions Strategic alternatives evaluation progressing well Company maintains outlook for fiscal 2025 Webcast: Wednesday, August 6, 2025,

Galecto Reports Second Quarter 2025 Operating and Financial Results

(NASDAQ:GLTO), BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, announced its operating and financial results for the quarter ended June 30, 2025. “We remain focused on advancing our lead program, GB3226, a dual ENL-YEATS and FLT3

Scroll to Top